Aaron Berg - Amarin PLC Senior Vice President - Marketing and Sales
| AMRN Stock | USD 0.86 0.01 1.15% |
President
Mr. Aaron D. Berg is Senior Vice President, Chief Commercial Officer of the Company. Before joining Amarin, Mr. Berg was with Essentialis, Inc. from 2009 to 2012, where he led the companys work on triglyceride management as President and Chief Executive Officer. Prior to joining Essentialis, Mr. Berg was with Kos Pharmaceuticals for six years, and as Vice President of Marketing and Sales at Kos Pharmaceuticals contributed to the acquisition of Kos by Abbott Laboratories. Prior to his position with Kos Pharmaceuticals, Mr. Berg began his pharmaceutical industry career as a sales representative with BristolMyers Squibb, followed by various positions with ScheringPlough and GlaxoSmithKline. since 2018.
| Age | 61 |
| Tenure | 6 years |
| Address | Iconic Offices, The Greenway, Dublin, Ireland, 112-114 |
| Phone | 353 0 166 99020 |
| Web | https://www.amarincorp.com |
Amarin PLC Management Efficiency
The company has return on total asset (ROA) of (0.0127) % which means that it has lost $0.0127 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.103) %, meaning that it created substantial loss on money invested by shareholders. Amarin PLC's management efficiency ratios could be used to measure how well Amarin PLC manages its routine affairs as well as how well it operates its assets and liabilities. As of the 19th of April 2024, Return On Tangible Assets is likely to drop to -0.08. In addition to that, Return On Capital Employed is likely to drop to -0.03. At this time, Amarin PLC's Asset Turnover is very stable compared to the past year.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Phil Thomson | GlaxoSmithKline PLC ADR | N/A | |
| Joseph Wolk | Johnson Johnson | 54 | |
| Daniel Karp | Biogen Inc | 40 | |
| Mirian GraddickWeir | Merck Company | 62 | |
| David Reese | Amgen Inc | 55 | |
| Suresh Kumar | Sanofi ADR | N/A | |
| Cristal Downing | Merck Company | 55 | |
| Timothy Richmond | AbbVie Inc | 58 | |
| Pam Cheng | AstraZeneca PLC ADR | 54 | |
| Andrew Dickinson | Gilead Sciences | 54 | |
| Luc Debruyne | GlaxoSmithKline PLC ADR | N/A | |
| Taiyin Yang | Gilead Sciences | 59 | |
| Frank Clyburn | Merck Company | 54 | |
| Jeffrey Capello | Biogen Inc | 53 | |
| Joseph Caldarella | Bristol Myers Squibb | 61 | |
| Dieter Weinand | Sanofi ADR | 57 | |
| Thomas Hurwich | AbbVie Inc | 54 | |
| Laura Hamill | Gilead Sciences | 53 | |
| Nick Hirons | GlaxoSmithKline PLC ADR | N/A | |
| Iskra Reic | AstraZeneca PLC ADR | N/A | |
| Brian McNamee | Amgen Inc | 59 | |
Management Performance
| Return On Equity | -0.1 | ||||
| Return On Asset | -0.0127 |
Amarin PLC Leadership Team
Elected by the shareholders, the Amarin PLC's board of directors comprises two types of representatives: Amarin PLC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Amarin. The board's role is to monitor Amarin PLC's management team and ensure that shareholders' interests are well served. Amarin PLC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Amarin PLC's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jason JD, Chief VP | ||
| Joseph JD, Exec Counsel | ||
| Jordan Zwick, Senior Relations | ||
| Aaron Berg, Senior Vice President - Marketing and Sales | ||
| Kristine Peterson, Non-Executive Independent Director | ||
| Lars Ekman, Independent Chairman of the Board | ||
| Mark Salyer, Chief Commercial Officer | ||
| Craig Granowitz, Chief Medical Officer | ||
| David Stack, Independent Director | ||
| Joseph Kennedy, Senior Vice President Chief Compliance Officer, General Counsel, Secretary | ||
| Thomas Reilly, Chief Officer | ||
| Steven Ketchum, President Officer | ||
| Lisa DeFrancesco, Sr Relations | ||
| Jan Heek, Non-Executive Independent Director | ||
| Alina Kolomeyer, Director Communications | ||
| Patrick Holt, CEO President | ||
| Nabil Abadir, Chief Affairs | ||
| James Healy, Non-Executive Independent Director | ||
| John Thero, CEO and President Assistant Secretary and Director | ||
| Stephen Ketchum, President - Research and Development, Senior Vice President | ||
| Gwen Fisher, Vice President - Corporate Communications | ||
| David Keenan, Executive Europe | ||
| Patrick OSullivan, Non-Executive Independent Director | ||
| Jonathan Provoost, Executive Officer | ||
| Michael Kalb, CFO, Senior Vice President | ||
| Laurent Abuaf, President VP | ||
| Donna Pasek, Senior Resources | ||
| Michael Farrell, Principal Financial Officer, Principal Accounting Officer and VP of Fin. | ||
| Karim Mikhail, CEO Pres | ||
| Van Heek, Non-Executive Independent Director | ||
| Joseph Zakrzewski, Director |
Amarin Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Amarin PLC a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.1 | ||||
| Return On Asset | -0.0127 | ||||
| Profit Margin | (0.19) % | ||||
| Operating Margin | (0.06) % | ||||
| Current Valuation | 66.58 M | ||||
| Shares Outstanding | 401.36 M | ||||
| Shares Owned By Insiders | 1.54 % | ||||
| Shares Owned By Institutions | 23.80 % | ||||
| Number Of Shares Shorted | 18.02 M | ||||
| Price To Earning | 590.00 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Amarin PLC in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Amarin PLC's short interest history, or implied volatility extrapolated from Amarin PLC options trading.
Pair Trading with Amarin PLC
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amarin PLC position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amarin PLC will appreciate offsetting losses from the drop in the long position's value.Moving against Amarin Stock
| 0.55 | MRSN | Mersana Therapeutics Financial Report 14th of May 2024 | PairCorr |
| 0.55 | NUVB | Nuvation Bio Financial Report 2nd of May 2024 | PairCorr |
| 0.52 | IMMP | Immutep Ltd ADR | PairCorr |
| 0.5 | IOVA | Iovance Biotherapeutics Financial Report 14th of May 2024 | PairCorr |
| 0.43 | ZNTL | Zentalis PharmaceuticalsL Buyout Trend | PairCorr |
The ability to find closely correlated positions to Amarin PLC could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amarin PLC when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amarin PLC - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amarin PLC to buy it.
The correlation of Amarin PLC is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amarin PLC moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amarin PLC moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amarin PLC can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amarin PLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Amarin Stock, please use our How to Invest in Amarin PLC guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for Amarin Stock analysis
When running Amarin PLC's price analysis, check to measure Amarin PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amarin PLC is operating at the current time. Most of Amarin PLC's value examination focuses on studying past and present price action to predict the probability of Amarin PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amarin PLC's price. Additionally, you may evaluate how the addition of Amarin PLC to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
Is Amarin PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amarin PLC. If investors know Amarin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amarin PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.94) | Earnings Share (0.15) | Revenue Per Share 0.753 | Quarterly Revenue Growth (0.17) | Return On Assets (0.01) |
The market value of Amarin PLC is measured differently than its book value, which is the value of Amarin that is recorded on the company's balance sheet. Investors also form their own opinion of Amarin PLC's value that differs from its market value or its book value, called intrinsic value, which is Amarin PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amarin PLC's market value can be influenced by many factors that don't directly affect Amarin PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amarin PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amarin PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amarin PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.